Filing Details
- Accession Number:
- 0001140361-22-007763
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-03 19:02:30
- Reporting Period:
- 2022-03-01
- Accepted Time:
- 2022-03-03 19:02:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1604464 | Atara Biotherapeutics Inc. | ATRA | Biological Products, (No Disgnostic Substances) (2836) | 460920988 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1809916 | Amar Murugan | C/O Atara Biotherapeutics, Inc. 611 Gateway Boulevard,Suite 900 South San Francisco CA 94080 | Svp, Gc & Secretary | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-03-01 | 51,814 | $0.00 | 139,535 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2022-03-01 | 1,465 | $9.86 | 138,070 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-03-01 | 1,112 | $9.86 | 136,958 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Acquisiton | 2022-03-01 | 97,398 | $0.00 | 97,398 | $10.21 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 97,398 | 2032-02-28 | No | 4 | A | Direct |
Footnotes
- These restricted stock units vest in 16 equal quarterly installments on each Company Quarterly Vesting Date (as defined below), with the initial installment vesting on May 15, 2022, subject to the reporting person's continuous service. Company Quarterly Vesting Date means March 1, May 15, August 15 and November 15 of each year.
- Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations in connection with the vesting of previously granted restricted stock units.
- The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on March 1, 2022 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employee.
- 1/48th of the shares subject to the stock option vest and become exercisable each month with the initial installment vesting on April 1, 2022, subject to the reporting person's continuous service.
- Includes 181 shares purchased under the Issuer's Employee Stock Purchase Plan on November 30, 2021.
Billionaire Hedge Funds
